Abstract
DPP9 overcomes oxidative stress and suppresses ferroptosis in ccRCC by binding to KEAP1 and promoting NRF2 stability, which drives tumor development and sorafenib resistance.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have